|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| A61K 39/00 | |||
| A61K 39/395 | |||
| C07K 16/22 |
| (11) | Patento numeris | 2688910 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12711543.4 |
| Europos patento paraiškos padavimo data | 2012-03-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/030364 |
| Data | 2012-03-23 |
| (87) | Numeris | WO 2012/135035 |
| Data | 2012-10-04 |
| (30) | Numeris | Data | Šalis |
| 201161467868 P | 2011-03-25 | US |
| (72) |
CLOGSTON, Christi, L., US
CHRISTIAN, Twinkle, R., US
OSSLUND, Timothy, D., US
FREEMAN, Elisabeth, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | ANTI-SCLEROSTIN ANTIBODY CRYSTALS AND FORMULATIONS THEREOF |
| ANTI-SCLEROSTIN ANTIBODY CRYSTALS AND FORMULATIONS THEREOF |